These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 29898630)
1. Severe Shah PJ; Koshy J; Everett N; Attia E J Pharm Pract; 2020 Feb; 33(1):108-112. PubMed ID: 29898630 [TBL] [Abstract][Full Text] [Related]
2. Artesunate: investigational drug for the treatment of severe falciparum malaria in Hawai'i. Callender DM; Hsue G Hawaii Med J; 2011 Apr; 70(4):77-9. PubMed ID: 21785506 [TBL] [Abstract][Full Text] [Related]
3. A Case of Plasmodium falciparum Malaria Treated with Artesunate in a 55-Year-Old Woman on Return to Florida from a Visit to Ghana. Rodriguez JA; Roa AA; Leonso-Bravo AA; Khatiwada P; Eckardt P; Lemos-Ramirez J Am J Case Rep; 2020 Dec; 21():e926097. PubMed ID: 33341821 [TBL] [Abstract][Full Text] [Related]
6. Intravenous Artesunate for the Treatment of Severe and Complicated Malaria in the United States: Clinical Use Under an Investigational New Drug Protocol. Twomey PS; Smith BL; McDermott C; Novitt-Moreno A; McCarthy W; Kachur SP; Arguin PM Ann Intern Med; 2015 Oct; 163(7):498-506. PubMed ID: 26301474 [TBL] [Abstract][Full Text] [Related]
8. Intravenous Artesunate for Imported Severe Malaria in Children Treated in Four Tertiary Care Centers in Germany: A Retrospective Study. Bélard S; Brand J; Schulze-Sturm U; Janda A; von Both U; Tacoli C; Alberer M; Kempf C; Stegemann MS; Krüger R; Varnholt V; Blohm M; Reiter K; Zoller T; Suttorp N; Mall M; von Bernuth H; Gratopp A; Hübner J; Hufnagel M; Kobbe R; Kurth F Pediatr Infect Dis J; 2019 Nov; 38(11):e295-e300. PubMed ID: 31626041 [TBL] [Abstract][Full Text] [Related]
9. Recrudescence of a high parasitaemia, severe Plasmodium falciparum malaria episode, treated by artesunate monotherapy. Landre S; Bienvenu AL; Miailhes P; Abraham P; Simon M; Becker A; Conrad A; Bonnot G; Kouakou YI; Chidiac C; Leboucher G; Rimmelé T; Argaud L; Picot S Int J Infect Dis; 2021 Apr; 105():345-348. PubMed ID: 33636354 [TBL] [Abstract][Full Text] [Related]
10. Expanded Availability of Intravenous Artesunate for the Treatment of Severe Malaria in the United States. Rosenthal PJ; Tan KR Am J Trop Med Hyg; 2019 Jun; 100(6):1295-1296. PubMed ID: 30927931 [No Abstract] [Full Text] [Related]
11. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy. Barber BE; William T; Grigg MJ; Menon J; Auburn S; Marfurt J; Anstey NM; Yeo TW Clin Infect Dis; 2013 Feb; 56(3):383-97. PubMed ID: 23087389 [TBL] [Abstract][Full Text] [Related]
12. Severe Malaria Treatment in the United States at the Precipice. Krey RA; Travassos MA Ann Intern Med; 2019 Sep; 171(5):362-363. PubMed ID: 31426092 [No Abstract] [Full Text] [Related]
13. Blackwater fever in a non-immune patient with Plasmodium falciparum malaria after intravenous artesunate. Rodriguez-Valero N; Castro P; Martinez G; Marco Hernandez J; Fernandez S; Gascon J; Nicolas JM J Travel Med; 2018 Jan; 25(1):. PubMed ID: 29394389 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of SOFA score and artesunate - based treatment in severe malaria – a single center study. Makowiecki M; Bednarska A; Paciorek M; Kowalska J; Skrzat-Klapaczyńska A; Puła J; Sosińska-Bryła I; Krogulec D; Raczyńska J; Hackiewicz M; Stengiel J; Bursa D; Pihowicz A; Horban A Przegl Epidemiol; 2018; 72(2):215-221. PubMed ID: 30111077 [TBL] [Abstract][Full Text] [Related]
15. Delayed haemolysis after artesunate therapy in a cohort of patients with severe imported malaria due to Plasmodium falciparum. Gómez-Junyent J; Ruiz-Panales P; Calvo-Cano A; Gascón J; Muñoz J Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):516-519. PubMed ID: 26708338 [TBL] [Abstract][Full Text] [Related]
16. Intravenous artesunate for the treatment of severe malaria. Hess KM; Goad JA; Arguin PM Ann Pharmacother; 2010; 44(7-8):1250-8. PubMed ID: 20551300 [TBL] [Abstract][Full Text] [Related]
17. Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine. Byakika-Kibwika P; Ssenyonga R; Lamorde M; Blessborn D; Tarning J BMC Infect Dis; 2019 Dec; 19(1):1025. PubMed ID: 31795967 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Pyronaridine-Artesunate for the Treatment of Uncomplicated Han KT; Lin K; Han ZY; Myint MK; Aye KH; Thi A; Thapa B; Bustos MD; Borghini-Fuhrer I; Ringwald P; Duparc S Am J Trop Med Hyg; 2020 Sep; 103(3):1088-1093. PubMed ID: 32524960 [TBL] [Abstract][Full Text] [Related]
19. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Rogers WO; Sem R; Tero T; Chim P; Lim P; Muth S; Socheat D; Ariey F; Wongsrichanalai C Malar J; 2009 Jan; 8():10. PubMed ID: 19138388 [TBL] [Abstract][Full Text] [Related]
20. Acute pancreatitis and subdural haematoma in a patient with severe falciparum malaria: case report and review of literature. Seshadri P; Dev AV; Viggeswarpu S; Sathyendra S; Peter JV Malar J; 2008 May; 7():97. PubMed ID: 18510778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]